首页>
外国专利>
CHARACTERIZATION OF POTENTIAL ANTIDIABETIC COMPOUND FROM PADINA BOERGESEN II ALLENDER AND KRAFT AND KRAFT AND ITS EFFECT ON STREPTOZOTOCIN INDUCED DIABETIC RATS
CHARACTERIZATION OF POTENTIAL ANTIDIABETIC COMPOUND FROM PADINA BOERGESEN II ALLENDER AND KRAFT AND KRAFT AND ITS EFFECT ON STREPTOZOTOCIN INDUCED DIABETIC RATS
展开▼
机译:PADINA BOERGESEN II ALLENDER和牛皮纸和牛皮纸的潜在抗糖尿病化合物的表征及其对链脲佐菌素诱导的糖尿病大鼠的作用
展开▼
页面导航
摘要
著录项
相似文献
摘要
ABSTRACT OF THE INVENTION Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. According to the International Diabetic Federation, there are more than 371 million people worldwide suffering from diabetes in 2012 and this number is likely to rise even to 552 million by 2030. Seaweeds identified as rich sources of structurally diverse bioactive compounds with great pharmaceutical and biomedical potential in particular, antidiabetic activity. Hence, the present study was carried out to isolate the antidiabetic compound from aqueous extract of Padina boergesenii. Column chromatography and Thin layer column chromatography for the separation of active constituents; Fourier transforms infrared (FTIR) spectroscopy for analysis of the phytoconstituents functional groups; identification of the structure of the active constituents by Nuclear Magnetic Resonance (NMR) spectroscopy: two dimensional nuclear magnetic resonance (2D NMR) spectroscopy for resolving and identifying the nature of chemical sites in the sample; !H - !H COSY (Homonuclear Correlation Spectroscopy) for revealing correlations between coupled protons; the overall analysis indicating a structure of the active constituent of the said extract with a molecular formula = C8Hi603, Molecular weight: 160.21 Da and the Compound name: 3-Hydroxy Octanoic acid.
展开▼
机译:发明内容糖尿病是一种慢性疾病,其发生在胰腺无法产生足够的胰岛素或人体无法有效利用其产生的胰岛素时。根据国际糖尿病联合会的数据,2012年全球糖尿病患者超过3.71亿,到2030年,这一数字甚至可能上升至5.52亿。海藻被认为是结构多样的生物活性化合物的丰富来源,具有巨大的药物和生物医学潜力特别是抗糖尿病活性。因此,进行了本研究以从博德氏帕金森氏菌的水提取物中分离抗糖尿病化合物。柱色谱法和薄层柱色谱法分离活性成分;傅里叶变换红外(FTIR)光谱用于分析植物成分官能团;通过核磁共振(NMR)光谱鉴定活性成分的结构:二维核磁共振(2D NMR)光谱,用于解析和鉴定样品中化学位点的性质; !H-!H COZY(单核相关光谱法),用于揭示耦合质子之间的相关性;整体分析表明,所述提取物的活性成分的结构为分子式= C 8 Hi 603,分子量:160.21Da,化合物名称:3-羟基辛酸。
展开▼